Recode Therapeutics, Inc.

CIK 1693764 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Recode Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Oct 23, 2025D0000905148-25-003655
Sep 28, 2023D/A0001994646-23-000002
Jan 27, 2023D/A0001693764-23-000002
Jul 6, 2022D/A0001693764-22-000001
Oct 25, 2021D0001693764-21-000001
Mar 20, 2020D0001693764-20-000002
Feb 8, 2019D/A0001693764-19-000001
Mar 2, 2017D/A0001693764-17-000002
Jan 5, 2017D0001693764-17-000001